Renaissance Technologies - ALX ONCOLOGY HLDGS INC ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ALX ONCOLOGY HLDGS INC
ValueSharesWeighting
Q3 2023$1,020
-25.7%
212,500
+16.2%
0.00%0.0%
Q2 2023$1,373
+139.6%
182,800
+44.1%
0.00%
+100.0%
Q1 2023$573
-46.9%
126,819
+32.4%
0.00%0.0%
Q4 2022$1,080
-99.9%
95,800
-43.8%
0.00%
-50.0%
Q3 2022$1,633,000
-11.3%
170,600
-25.1%
0.00%0.0%
Q2 2022$1,842,000
-26.8%
227,683
+53.0%
0.00%
-33.3%
Q1 2022$2,515,000
-30.3%
148,800
-11.4%
0.00%
-25.0%
Q4 2021$3,608,000167,9000.00%
Other shareholders
ALX ONCOLOGY HLDGS INC shareholders Q4 2023
NameSharesValueWeighting ↓
venBio Partners LLC 9,699,925$530,392,00062.60%
Logos Global Management LP 3,156,981$172,624,00014.51%
Vivo Capital, LLC 4,220,048$230,752,0009.99%
Foresite Capital Management V, LLC 231,200$12,642,0004.97%
Cormorant Asset Management, LP 889,454$48,635,0001.65%
Board of Trustees of The Leland Stanford Junior University 259,982$14,216,0001.33%
Redmile Group, LLC 914,035$49,979,0000.74%
SPHERA FUNDS MANAGEMENT LTD. 192,728$10,538,0000.71%
Financial Advisory Group 54,041$2,955,0000.71%
Nan Fung Group Holdings Ltd 34,950$1,911,0000.59%
View complete list of ALX ONCOLOGY HLDGS INC shareholders